Evommune, a pioneering biotech company, is at the forefront of developing innovative therapies for chronic inflammatory diseases to halt disease progression and offer long-term solutions to patients. Their lead program targets mast cell receptors and sensory neurons, addressing various mast cell-mediated diseases and chronic itch, where current treatments are often ineffective. Evommune’s approach helps the […]





